In a very recent research, we reported the identification as well as characterization of a completely new atypical opioid receptor with exclusive detrimental regulatory properties in the direction of opioid peptides.1 Our final results confirmed that ACKR3/CXCR7, hitherto often called an atypical scavenger receptor for chemokines CXCL12 and CXCL11, https://mitradine72737.daneblogger.com/26643337/the-basic-principles-of-block-pain-receptors-with-proleviate